Authors: Jarasiene-Burinskaja, Rasa
Alksne, Milda
Bartuskiene, Violeta
Voisniene, Violeta
Burinskij, Jaroslav
Cenas, Narimantas
Bukelskiene, Virginija
Title: Study of the cytotoxic effects of 2,5-diaziridinyl-3,6-dimethyl-1,4-benzoquinone (MeDZQ) in mouse hepatoma cells
Language (ISO): en
Abstract: A number of quinones have been shown to be efficient anticancer agents. However, some mechanisms of their action, in particular cell signaling are not well understood. The aim of this study was to partly fill this gap by characterizing the mode of cytotoxicity of 2,5-diaziridinyl-3,6-dimethyl-1,4-benzoquinone (MeDZQ) in malignant mouse hepatoma cells (MH-22A) with regard to the expression and activation of main molecules in MAPK cell signaling pathway. The study revealed unequal roles of MAP kinases in MeDZQ-induced cell death: the compound did not induce significant changes in ERK expression or its phosphorylation; JNK appeared to be responsible for cell survival, however, p38 kinase was shown to be involved in cell death. In order to assess the enzymatic activation mechanisms responsible for the action of MeDZQ, we have also found that the antioxidant N,N'-diphenyl-pphenylene diamine, the iron-chelating agent desferrioxamine, and DT-diaphorase inhibitor, dicoumarol, partly protected the cells from MeDZQ cytotoxicity. It points to parallel oxidative stress and bioreductive alkylation modes of the cytotoxicity of MeDZQ.
Subject Headings: aziridinylbenzoquinones
cytotoxicity
cell signaling
cell death
MeDZQ
URI: http://hdl.handle.net/2003/36063
http://dx.doi.org/10.17877/DE290R-18079
Issue Date: 2017-03-06
Appears in Collections:Original Articles

Files in This Item:
File Description SizeFormat 
Bukelskiene_06032017_proof.pdfDNB394.64 kBAdobe PDFView/Open


This item is protected by original copyright



All resources in the repository are protected by copyright.